The Enhanced Research and Development Tax Credit for Small Businesses in Delaware: Statutory Definition, IRC Nexus, and Division of Revenue Compliance

A Delaware small business for R&D tax credit purposes is defined as a taxpayer whose average annual gross receipts (AAGR) do not exceed $20 million. This qualification grants access to dramatically enhanced refundable credit rates, serving as a critical financial incentive for early-stage and high-growth technology firms operating within the state.

The small business distinction, codified under 30 Del. C. § 2070(a)(2), allows qualifying taxpayers to claim either 20% of their excess Qualified Research Expenses (QREs) over the base amount (up from the standard 10%) or 100% of Delaware’s apportioned share of the federal Alternative Simplified Credit (ASC) (up from the standard 50%).1

Section 1: Statutory Foundation of the Delaware Small Business Definition

1.1. Statutory Authority and Legislative Intent

The Delaware Research and Development (R&D) Tax Credit program is administered pursuant to Title 30, Chapter 20, Subchapter VIII, Section 2070 of the Delaware Code.1 The state maintains this credit as a key economic development tool, particularly designed to foster innovation among technology, manufacturing, and life science enterprises.3 The program includes a specific, substantial enhancement for smaller entities, reflecting a strategic effort to encourage growth and research investment among startups and mid-sized firms.1

The credit is unique in that it is fully refundable, meaning that if the credit amount exceeds the taxpayer’s Delaware income tax liability, the unused portion is paid directly to the taxpayer, providing essential cash flow rather than just a future liability offset.1

1.2. Defining the Small Business: The $20 Million Gross Receipts Threshold

The statutory language governing the definition of a small business is precise and hinges entirely on federal tax law standards. The Delaware Code provides the following directive:

For the purposes of this subsection, “small business” means any taxpayer with average annual gross receipts, as determined by § 41(c)(1)(B) of the Internal Revenue Code of 1986, not in excess of the applicable threshold of $20,000,000.2

This mandate creates a legal linkage between the state incentive and the technical requirements of the federal R&D tax credit regime. The threshold itself is set at $20,000,000 in average annual gross receipts (AAGR).1

The determination of AAGR under IRC $\S 41(\text{c})(1)(\text{B})$ requires averaging the taxpayer’s annual gross receipts for the four taxable years immediately preceding the credit year.7 This four-year lookback mechanism is intended to provide businesses with a stable measure of size, ensuring that brief periods of high revenue do not immediately disqualify a business from receiving the enhanced rate.

1.3. Gross Receipts Definition: Adhering to IRC Standards

A crucial technical point arises from the difference between the gross receipts definition used by the federal Internal Revenue Code (IRC) for R&D purposes and the definition utilized by the Delaware Division of Revenue (DOR) for its state Gross Receipts Tax (GRT).9

The Delaware GRT is a levy on the total gross revenues of a business, encompassing all sources regardless of deductions for costs of goods sold, labor, or operating expenses.9 This definition is exceedingly broad. However, for R&D tax credit eligibility, the statute specifically dictates the use of the federal IRC $\S 41$ methodology. For R&D credit purposes, federal guidance defines gross receipts generally as total sales (net of returns and allowances) and all amounts received for services.10 Taxpayers must meticulously separate these two definitions. Utilizing the broader state GRT definition when calculating the AAGR for R&D credit eligibility could inadvertently inflate a company’s average annual gross receipts, potentially causing them to exceed the $20 million statutory limit and thus forfeiting the enhanced credit rate. Proper compliance necessitates stringent adherence to the more precise federal standards.

Section 2: Technical Interpretation: Federal Aggregation and Operationalizing AAGR

2.1. Calculation Methodology for AAGR

To determine whether a business satisfies the $\le \$20$ million AAGR requirement, the taxpayer must first identify the relevant four-year lookback period. If the credit is claimed for the 2024 tax year, the AAGR calculation must cover the aggregated gross receipts from 2020, 2021, 2022, and 2023.

The definition of gross receipts for this purpose includes revenues from total sales and services rendered.10 Furthermore, technical rules require the gross receipts of any taxable year shorter than 12 months to be annualized. This is achieved by multiplying the gross receipts for the short period by 12 and dividing the result by the number of months in that period, preventing distortions in the four-year average that short tax years might otherwise cause.10

2.2. The Requirement of Aggregation for Controlled Groups

A frequently overlooked requirement of adopting the IRC $\S 41(\text{c})(1)(\text{B})$ standard is the mandatory application of federal controlled group aggregation rules. For purposes of the R&D credit, the IRC treats all related or commonly controlled entities as a single taxpayer.10

The consequence for the Delaware small business test is substantial: if a taxpayer is part of a larger corporate group (e.g., parent-subsidiary or brother-sister structures, where ownership generally exceeds 50% or 80% depending on the test) 11, the gross receipts of all members of that global controlled group must be aggregated when calculating the four-year AAGR.10

This aggregation requirement imposes a global test for small business status. If a subsidiary operating in Delaware has gross receipts well below $20 million but is owned by a parent corporation whose consolidated average gross receipts exceed the threshold, the subsidiary is disqualified from claiming the enhanced Delaware credit. This structure ensures that the enhanced incentives are directed toward independently small or moderately sized companies, rather than serving as a mechanism for large, multi-state or multinational corporations to claim enhanced state benefits based solely on the size of their localized Delaware R&D operations. Taxpayers must perform a comprehensive review of their corporate structure and ownership interests to confirm that the aggregated group’s AAGR does not exceed the limit.

Section 3: Calculation Methodology and Maximizing the Small Business Benefit

A Delaware small business meeting the AAGR criterion receives a doubled credit rate under both of the available computation methods outlined in 30 Del. C. § 2070(a).2 The selection between the two methods is an annual, independent election, meaning the taxpayer’s choice for the Delaware credit is not tied to the method used for the federal R&D credit.2

3.1. Enhanced Method A: Traditional Incremental Credit

The Traditional Method calculates the credit based on the excess of current Qualified Research Expenses (QREs) over a historical “base amount.”

• Standard Calculation: 10% of the excess of total Delaware QREs over the Delaware base amount.1
• Small Business Enhancement: The rate is increased to 20% of the excess QREs over the base amount.2

The Delaware Base Amount is calculated by multiplying the Delaware Fixed-Base Percentage (DFBP) by the taxpayer’s AAGR for the four preceding years.12 Federal rules mandate that the base amount must not be less than 50% of the current year’s QREs.13

3.2. Enhanced Method B: Alternative Simplified Credit (ASC)

The ASC method simplifies the calculation by relying on the recent three years of QRE history, making it attractive for companies lacking extensive base period data or those with fluctuating expenses.

• Standard Calculation: 50% of Delaware’s apportioned share of the taxpayer’s federal ASC calculated using IRC $\S 41(\text{c})(5)$.1
• Small Business Enhancement: The apportionment percentage is increased to 100% of Delaware’s apportioned share of the federal ASC.1

The Delaware apportioned share is calculated as the total federal ASC multiplied by a ratio: Delaware QREs for the credit year divided by the taxpayer’s total global QREs for the credit year.2

3.3. Strategic Value of the 100% ASC Rate for Startups

For many high-growth, early-stage small businesses, Method B (the enhanced 100% ASC) often yields the highest credit value. The Traditional Method (Method A) can present a high hurdle because of the statutory requirement that the base amount cannot be less than 50% of the current year’s QREs.13 For companies with rapidly accelerating R&D spending, this 50% floor substantially reduces the “excess QREs” portion, minimizing the benefit of the 20% rate.

In contrast, the 100% ASC rate (Method B) utilizes a simpler comparison based on the three prior years of QREs, potentially resulting in a larger final credit, especially for firms experiencing high QRE growth. Because the credit is fully refundable, maximizing the annual claim is paramount. Taxpayers are strongly advised to model both Method A (20%) and Method B (100%) annually to select the calculation that maximizes the refundable benefit for that tax period.4

Section 4: Division of Revenue (DOR) Compliance and Filing Requirements

The Delaware Division of Revenue (DOR) administers the R&D Tax Credit program. Compliance is governed by strict procedural requirements regarding forms, deadlines, and documentation.

4.1. The Application Process and Form 2071AC

The credit is claimed by submitting Form 2071AC, titled “Application and Computation Schedule for Claiming Delaware Research and Development Tax Credits”.12 This form requires taxpayers to detail the calculation of their base amount, including reporting their total Delaware gross receipts and their AAGR for the preceding four years, even if using Method B.12

A mandatory requirement is the attachment of a copy of the taxpayer’s Federal Form 6765 (Credit for Increasing Research Activities) to Form 2071AC.12 This linkage allows the DOR to verify the underlying QREs and the federal ASC calculation, which is essential for determining the Delaware apportioned share used in Method B.

4.2. Critical Filing Deadline and Penalty for Non-Compliance

The most critical procedural requirement is the filing deadline. Form 2071AC must be completed and submitted to the DOR on or before September 15th after the end of the taxable year during which the qualified R&D expenses were made.4

It must be noted that this September 15th date is statutory and does not automatically align with the standard extended deadline for filing the annual corporate or individual income tax return (Delaware Form 700). Failure to submit Form 2071AC by this specific deadline results in the permanent forfeiture of the R&D credit for that specific tax year. Strict adherence to this date is mandatory for claiming the benefit.

4.3. Utilization and Refundability

Upon approval by the DOR, the calculated credit amount from Form 2071AC is then transferred to the taxpayer’s Delaware Income Tax Credit Schedule, Form 700.14

For C-Corporations, the final credit is entered on Form 700, Line 10(a).12 For partnerships and other flow-through entities, the credit is multiplied by the percentage ownership of each partner or shareholder and allocated accordingly.12

The defining characteristic of the Delaware R&D credit is its refundability.4 If the approved credit amount exceeds the taxpayer’s income tax liability, the DOR issues a refund for the excess amount. This is a vital mechanism for early-stage small businesses, which often incur significant R&D expenditures but may have little or no taxable income, turning the tax incentive into direct operating cash flow.1

Section 5: Practical Case Study and Application Example

To illustrate the technical qualification and financial benefit, consider “Delaware BioTech, LLC,” a partnership engaged exclusively in research within the state, filing for the 2024 tax year. The entity is reviewing its eligibility for the small business enhancement.

5.1. Qualification Analysis: Applying the AAGR Test

As an LLC taxed as a partnership, Delaware BioTech must determine its small business status based on the aggregated AAGR of its partners or related entities, per the federal controlled group rules.

Aggregated Financial Data (Applying IRC § 41(c)(1)(B)):

Since the calculated AAGR ($10,000,000) is not in excess of the $20,000,000 statutory threshold, Delaware BioTech, LLC qualifies as a Delaware Small Business and is eligible for the enhanced rates.

R&D Expenses for 2024 (Credit Year):

• 2024 Delaware QREs: $1,500,000
• 2024 Total Global QREs: $1,500,000 (100% performed in Delaware)

5.2. Calculation Comparison: Small Business vs. Standard Rate

Assuming the company opts for Method A (Traditional) and, based on its historical QRE-to-Gross-Receipts ratio, calculates a Delaware Base Amount of $750,000 (which meets the 50% QRE floor).12 The Excess QREs are $750,000 ($1,500,000 QREs minus $750,000 Base Amount).

The difference created solely by the small business status is demonstrated below:

Delaware R&D Tax Credit Calculation Comparison (Method A)

The ability to use the 20% small business rate directly doubles the value of the credit realized from the R&D activities, yielding an additional $75,000 in refundable funds for this tax year. This amplification underscores the importance of correctly determining small business status.

5.3. Documentation and Audit Readiness

To ensure the claimed credit is secured and defensible during a review by the DOR, the taxpayer must maintain robust documentation specific to the small business determination. This includes detailed schedules confirming that the four-year lookback AAGR was calculated using the appropriate IRC definitions, not the broader Delaware GRT definition. Further, if the entity is part of a larger controlled group, documentation proving the aggregation of all group members’ gross receipts and the group’s ultimate compliance with the $\le \$20$ million threshold is necessary. Finally, the timely submission of Form 2071AC by the September 15th deadline, along with the required Federal Form 6765, is essential.14

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/